• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化患者等待肝移植的管理。

Management of patients with cirrhosis awaiting liver transplantation.

机构信息

GI Unit, Institut Clinic de Malalties Digestives i Metaboliques, Hospital Clinic,and University of Barcelona, Institut d’Investigacions Biomédiques August Pi-Sunyer (IDIBAPS), Ciber de Enfermedades Hepáticas y Digestivas (CIBEREHD), Barcelona, Spain.

出版信息

Gut. 2011 Mar;60(3):412-21. doi: 10.1136/gut.2009.179937. Epub 2010 Dec 30.

DOI:10.1136/gut.2009.179937
PMID:21193458
Abstract

The demand for OLT continues to be on the rise with patients spending a long time on the waiting list; this not only increases the risk of developing further decompensation but also mortality. The complications discussed above may not only lead to removal from the waiting list in some cases but also a poorer outcome following transplantation. Therefore the appropriate prevention, recognition and treatment of the above-mentioned complications of cirrhosis will have a positive impact on the outcome before and after liver transplantation.

摘要

OLT 的需求持续上升,患者在等待名单上等待的时间很长;这不仅增加了进一步恶化和死亡的风险。上述并发症不仅可能导致在某些情况下从等待名单中移除,而且还可能导致移植后预后更差。因此,适当预防、识别和治疗肝硬化的上述并发症将对肝移植前后的结果产生积极影响。

相似文献

1
Management of patients with cirrhosis awaiting liver transplantation.肝硬化患者等待肝移植的管理。
Gut. 2011 Mar;60(3):412-21. doi: 10.1136/gut.2009.179937. Epub 2010 Dec 30.
2
[Therapy of liver cirrhosis. Managing complications with fingertip control].[肝硬化的治疗。通过精准控制管理并发症]
MMW Fortschr Med. 2001 Jul 5;143(26-27):34-7.
3
[Liver cirrhosis and its complications. Kidney and brain also suffer].[肝硬化及其并发症。肾脏和大脑也会受累]
MMW Fortschr Med. 2010 May 13;152(19):12-4, 16. doi: 10.1007/BF03366535.
4
[Complications of liver cirrhosis: portal hypertension, gastroesophageal varices and ascites].肝硬化的并发症:门静脉高压、胃食管静脉曲张和腹水
Praxis (Bern 1994). 2003 Aug 27;92(35):1427-34. doi: 10.1024/0369-8394.92.35.1427.
5
[Complications of liver cirrhosis. Is it still possible to help these patients?].
MMW Fortschr Med. 2008 Jan 24;150(3-4):12-5. doi: 10.1007/BF03365289.
6
Management of end-stage liver disease.终末期肝病的管理。
Med Clin North Am. 2014 Jan;98(1):119-52. doi: 10.1016/j.mcna.2013.09.006. Epub 2013 Oct 30.
7
Complications of cirrhosis.肝硬化的并发症。
Dis Mon. 2008 Jul;54(7):445-56. doi: 10.1016/j.disamonth.2008.03.006.
8
[Therapy of complications of hepatic cirrhosis].[肝硬化并发症的治疗]
Praxis (Bern 1994). 2005 May 4;94(18):727-33. doi: 10.1024/0369-8394.94.18.727.
9
Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.2型肝肾综合征与顽固性腹水:经颈静脉肝内门体分流术在18例等待原位肝移植的晚期肝硬化患者中的作用
Hepatogastroenterology. 2003 Nov-Dec;50(54):1753-5.
10
Complications and outcomes in chronic liver disease.慢性肝脏疾病的并发症和结果。
Curr Opin Gastroenterol. 2011 May;27(3):204-9. doi: 10.1097/MOG.0b013e3283460c7d.

引用本文的文献

1
Hospital admissions for chronic liver diseases: a temporal study in the South Region of Brazil.慢性肝脏疾病住院患者:巴西南部地区的一项时间研究。
Rev Assoc Med Bras (1992). 2024 May 20;70(5):e20231430. doi: 10.1590/1806-9282.20231430. eCollection 2024.
2
Factors Associated with in-Hospital Mortality in Malagasy Patients with Acute Decompensation of Liver Cirrhosis: A Retrospective Cohort.马达加斯加肝硬化急性失代偿患者院内死亡的相关因素:一项回顾性队列研究
Hepat Med. 2023 Mar 12;15:21-26. doi: 10.2147/HMER.S401628. eCollection 2023.
3
Therapeutic Cell Repopulation of the Liver: From Fetal Rat Cells to Synthetic Human Tissues.
肝脏的治疗性细胞再群体化:从胎鼠细胞到合成的人类组织。
Cells. 2023 Feb 6;12(4):529. doi: 10.3390/cells12040529.
4
A potential novel inflammation biomarker for predicting the prognosis of decompensated liver cirrhosis.一种潜在的新型炎症生物标志物,可预测失代偿期肝硬化的预后。
Ann Med. 2022 Dec;54(1):3201-3210. doi: 10.1080/07853890.2022.2142277.
5
Evaluation of Laboratory and Sonographic Parameters for Detection of Portal Hypertension in Patients with Common Variable Immunodeficiency.评价实验室和超声参数在普通可变免疫缺陷患者中检测门静脉高压的价值。
J Clin Immunol. 2022 Nov;42(8):1626-1637. doi: 10.1007/s10875-022-01319-0. Epub 2022 Jul 11.
6
Soluble CD163 Is a Predictor of Mortality in Patients With Decompensated Cirrhosis.可溶性CD163是失代偿期肝硬化患者死亡率的一个预测指标。
Front Med (Lausanne). 2021 Jul 15;8:698502. doi: 10.3389/fmed.2021.698502. eCollection 2021.
7
Mortality rates and risk factors in 1412 Japanese patients with decompensated hepatitis C virus-related cirrhosis: a retrospective long-term cohort study.1412 例日本失代偿期丙型肝炎病毒相关肝硬化患者的死亡率和危险因素:一项回顾性长期队列研究。
BMC Gastroenterol. 2021 Apr 23;21(1):189. doi: 10.1186/s12876-021-01770-0.
8
Renal Dysfunction in Cirrhosis: Critical Care Management.肝硬化中的肾功能障碍:重症监护管理
Indian J Crit Care Med. 2021 Feb;25(2):207-214. doi: 10.5005/jp-journals-10071-23721.
9
Serum lactate level predicts 6-months mortality in patients with hepatitis B virus-related decompensated cirrhosis: a retrospective study.血清乳酸水平可预测乙型肝炎病毒相关失代偿性肝硬化患者 6 个月的死亡率:一项回顾性研究。
Epidemiol Infect. 2021 Jan 5;149:e26. doi: 10.1017/S0950268820003143.
10
Assessing the Prognostic Performance of the Child-Pugh, Model for End-Stage Liver Disease, and Albumin-Bilirubin Scores in Patients with Decompensated Cirrhosis: A Large Asian Cohort from Gastroenterology Department.评估失代偿性肝硬化患者 Child-Pugh、终末期肝病模型和白蛋白-胆红素评分的预后性能:来自消化内科的大型亚洲队列研究。
Dis Markers. 2020 Feb 15;2020:5193028. doi: 10.1155/2020/5193028. eCollection 2020.